These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 18187570)

  • 41. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells.
    Lwin T; Hazlehurst LA; Li Z; Dessureault S; Sotomayor E; Moscinski LC; Dalton WS; Tao J
    Leukemia; 2007 Jul; 21(7):1521-31. PubMed ID: 17476277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation.
    Kiss I; Unger C; Huu CN; Atanasov AG; Kramer N; Chatruphonprasert W; Brenner S; McKinnon R; Peschel A; Vasas A; Lajter I; Kain R; Saiko P; Szekeres T; Kenner L; Hassler MR; Diaz R; Frisch R; Dirsch VM; Jäger W; de Martin R; Bochkov VN; Passreiter CM; Peter-Vörösmarty B; Mader RM; Grusch M; Dolznig H; Kopp B; Zupko I; Hohmann J; Krupitza G
    Cancer Lett; 2015 Jan; 356(2 Pt B):994-1006. PubMed ID: 25444930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two cases of CD30+, anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with oral manifestations.
    Grandhi A; Boros AL; Berardo N; Reich RF; Freedman PD
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):e41-7. PubMed ID: 22940020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
    Baus D; Nonnenmacher F; Jankowski S; Döring C; Bräutigam C; Frank M; Hansmann ML; Pfitzner E
    Leukemia; 2009 Oct; 23(10):1885-93. PubMed ID: 19440213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
    Atsaves V; Lekakis L; Drakos E; Leventaki V; Ghaderi M; Baltatzis GE; Chioureas D; Jones D; Feretzaki M; Liakou C; Panayiotidis P; Gorgoulis V; Patsouris E; Medeiros LJ; Claret FX; Rassidakis GZ
    Br J Haematol; 2014 Nov; 167(4):514-23. PubMed ID: 25145835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin.
    Chen R; Hou J; Newman E; Kim Y; Donohue C; Liu X; Thomas SH; Forman SJ; Kane SE
    Mol Cancer Ther; 2015 Jun; 14(6):1376-84. PubMed ID: 25840583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease.
    Nishikori M; Maesako Y; Ueda C; Kurata M; Uchiyama T; Ohno H
    Blood; 2003 Apr; 101(7):2789-96. PubMed ID: 12456498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation.
    Miyagaki T; Sugaya M; Murakami T; Asano Y; Tada Y; Kadono T; Okochi H; Tamaki K; Sato S
    Cancer Res; 2011 Mar; 71(6):2056-65. PubMed ID: 21406396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.
    Mir SS; Richter BW; Duckett CS
    Blood; 2000 Dec; 96(13):4307-12. PubMed ID: 11110706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
    Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
    Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1).
    Pfeifer W; Levi E; Petrogiannis-Haliotis T; Lehmann L; Wang Z; Kadin ME
    Am J Pathol; 1999 Oct; 155(4):1353-9. PubMed ID: 10514417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
    Hsu PL; Hsu SM
    Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells.
    Schwarzer R; Dörken B; Jundt F
    Leukemia; 2012 Apr; 26(4):806-13. PubMed ID: 21946908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The action mechanisms of unclassical NF-kappaB activity and TRAF3 expression in Hodgkin's lymphoma cells].
    Guo F; Wang WJ; Sun AN; Zhou P; Chen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2009 Oct; 30(10):678-82. PubMed ID: 19954665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma.
    Watanabe M; Itoh K; Togano T; Kadin ME; Watanabe T; Higashihara M; Horie R
    Am J Pathol; 2012 Feb; 180(2):831-8. PubMed ID: 22107829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
    Buchan SL; Al-Shamkhani A
    PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-κB signaling.
    Kim A; Lee JE; Jang WS; Lee SJ; Park S; Kang HJ; Lee SS
    Leuk Res; 2012 Mar; 36(3):350-7. PubMed ID: 21893341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression and function of TRAF1 in Hodgkin's lymphoma cells.].
    Wang WJ; Guo F; Sun AN; Zhou P; Ma L
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):29-33. PubMed ID: 20302775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.
    Nishikori M; Ohno H; Haga H; Uchiyama T
    Cancer Sci; 2005 Aug; 96(8):487-97. PubMed ID: 16108830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas.
    Pinto A; Gloghini A; Gattei V; Aldinucci D; Zagonel V; Carbone A
    Blood; 1994 Feb; 83(3):785-92. PubMed ID: 7507733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.